Nabriva Therapeutics PLC (NASDAQ:NBRV)
| 0.5841 Delayed Data As of Sep 18 |  -0.0009 / -0.15%Today’s Change | 0.49 Today|||52-Week Range 2.35 | -55.75% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 6.5M | 5.3M | 9.7M | |
| Depreciation And Amortization | 153.0K | 233.0K | 432.0K | 510.0K | ||
| Operating Expenses | Gross Income | -153.0K | -- | -- | -- | |
| General Expenses | 30.8M | 61.3M | 78.0M | 91.5M | ||
| Other Operating Expenses | 0.00 | 0.00 | 700.0K | 0.00 | ||
| Research And Development | 23.0M | 47.9M | 49.6M | 50.2M | ||
| Total Operating Expenses | 31.0M | 61.5M | 79.1M | 92.0M | ||
| Non-Operating Expenses | Operating Income | -31.0M | -55.0M | -73.8M | -82.3M | |
| Extraordinary Credit | 6.8M | 0.00 | 0.00 | 0.00 | ||
| Extraordinary Charge | -9.4M | 0.00 | 0.00 | -32.0M | ||
| Interest Expense On Debt | 4.6M | 0.00 | 43.0K | 133.0K | ||
| Other Expenses | 2.2M | -858.0K | 492.0K | -272.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -35.9M | -55.6M | -73.0M | -114.7M | |
| Income Taxes | -4.0M | -672.0K | -1.4M | -49.0K | ||
| Net Income | -31.8M | -54.9M | -74.4M | -114.8M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 1.1M | 2.1M | 29.8M | 50.8M | |
| Shares To Calculate EPS Diluted | 1.1M | 2.1M | 29.8M | 50.8M | ||
| Earnings Per Share | EPS | -$30.07 | -$25.56 | -$2.49 | -$2.26 | |
| EPS Diluted | -$30.07 | -$25.56 | -$2.49 | -$2.26 | ||
